Sarcopenia in Patients After Cardiac Surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to measure the prevalence of sarcopenia in patients who have recently undergone cardiac surgery and to see if standard post-discharge care is sufficient to improve sarcopenia outcomes. Participants will be assessed for sarcopenia one day before hospital discharge and then again at 4 weeks, 16 weeks, and/or 1 year, depending on baseline status and participation in a cardiac rehabilitation program. The study follows existing guidelines on sarcopenia management and does not involve any experimental intervention. It describes real-world practice and associations between rehabilitation participation and sarcopenia trajectories in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Hospitalized following cardiac surgery (i.e. hospitalization unit 18 and 22)
* Stable with regard to symptoms
* Eligible for cardiac rehabilitation according to current guidelines following hospital discharge
* Voluntary written informed consent of the participant has been obtained
* At least 18 years of age at the time of signing the Informed Consent Form (ICF)

Exclusion Criteria:

* Not eligible for cardiac rehabilitation according to current guidelines
* Unable to perform the physical performance test due to physical or mental issues as up to decision by supervising cardiologist

Where it's running

• UZ Leuven
  Leuven, Belgium Recruiting

Study contacts

• Study coordinator: Véronique Cornelissen
• Email: veronique.cornelissen@kuleuven.be
• Phone: +3216329152

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Impact of Fast-Track Anesthesia on Postoperative Delirium After Cardiac Surgery

  This observational study tests whether fast-track anesthesia, compared with conventional care, is linked to lower rates of delirium after elective cardiac surgery in adults.

  Recruiting Second Affiliated Hospital of Nanchang University · Nanchang, Jiangxi · NCT07923344

• Bone marrow mesenchymal stem cell injection for sarcopenia

  This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.

  Recruiting Phase 1/2 GuangZhou Cellgenes Biotechnology Co., Ltd. · Guangzhou · NCT07865676

• GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes

  This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.

  Recruiting Istanbul Saglik Bilimleri University · Istanbul, Kucukcekmece · NCT07858864

• Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis

  We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.

  Recruiting Marmara University · Istanbul, Istanbul · NCT07855419

• Preoperative functional optimization for adults undergoing major cardiac or abdominal surgery

  This study tests a four‑week prehabilitation program to improve fitness before elective major cardiac or abdominal surgery.

  Recruiting ASST Sette Laghi · Varese, VA and 1 other locations · NCT07851350

• Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients

  This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.

  Recruiting Zhangzhou Municipal Hospital · Zhangzhou, Fujian · NCT07836088

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.